BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

PARMAXPHARMA01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

PARMAXPHARMA01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
02-May-2024	BC	Meeting of the Board of Directors of Parmax Pharma Limited held on 2nd May, 2024 at 5.00 pm at registered office of the company and board has approved the appointment of Ms. Bhakti Aghera as a compan	02-May-2024
02-May-2024	BC	Meeting of the Board of Directors of Parmax Pharma Limited held on 2nd May, 2024 at 5.00 pm at registered office of the company and board has approved the appointment of Ms. Bhakti Aghera as a compan	02-May-2024
07-Feb-2024	BC	Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Board Meeting intimation for unaudited financ	14-Feb-2024
31-Jan-2024	BC	Intimation for resignation of Company Secretary and Compliance officer.	31-Jan-2024
03-Nov-2023	BC	Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve Intimation of Board Meeting in compliance wit	10-Nov-2023

No Rights has been declared by PARMAXPHARMA

Book Closure

Record Date	Split Date	Purpose
02-May-2024	-	Meeting of the Board of Directors of Parmax Pharma Limited held on 2nd May, 2024 at 5.00 pm at registered office of the company and board has approved the appointment of Ms. Bhakti Aghera as a compan
02-May-2024	-	Meeting of the Board of Directors of Parmax Pharma Limited held on 2nd May, 2024 at 5.00 pm at registered office of the company and board has approved the appointment of Ms. Bhakti Aghera as a compan
14-Feb-2024	-	Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Board Meeting intimation for unaudited financ
31-Jan-2024	-	Intimation for resignation of Company Secretary and Compliance officer.
10-Nov-2023	-	Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve Intimation of Board Meeting in compliance wit

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,679.80(+25.05/1.51%)	1,679.80	+25.05	75,415.25	133.18	36.60	3.91
Ipca Laboratories Ltd ₹1,337.65(-0.05/0.00%)	1,337.65	-0.05	33,938.01	88.94	61.57	5.46
J B Chemicals & Pharmaceuticals Ltd ₹1,852.70(-37.20/-1.97%)	1,852.70	-37.20	29,330.27	80.31	57.90	10.92
Sanofi India Ltd ₹8,544.15(-80.10/-0.93%)	8,544.15	-80.10	19,861.65	59.17	33.61	19.54
IOL Chemicals & Pharmaceuticals Ltd ₹386.10(-9.45/-2.39%)	386.10	-9.45	2,322.10	-0.40	13.44	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	1.33	4.07	1.40	6.38	5.35	2.13
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1.33	4.07	1.40	6.38	5.35	2.13
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.01	0.01	0.01	0.01	0.01	0.01
Total Income	1.34	4.08	1.41	6.40	5.36	2.14
Total Expenditure	2.48	4.83	2.05	5.55	3.03	2.26
PBIDT	-1.14	-0.75	-0.64	0.85	2.33	-0.12
Interest	0.16	0.18	0.12	0.05	0.11	0.12
PBDT	-1.30	-0.94	-0.76	0.80	2.22	-0.24
Depreciation	0.45	0.43	0.42	0.47	0.48	0.47
Tax	0.00	0.00	0.00	0.19	0.00	0.00
Deferred Tax	0.00	0.00	0.00	-0.03	0.00	0.00
Reported Profit After Tax	-1.75	-1.37	-1.18	0.17	1.74	-0.70
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.75	-1.37	-1.18	0.17	1.74	-0.70

EPS (Unit Curr.)	-4.68	-3.66	-3.15	0.46	4.66	-1.88
EPS (Adj) (Unit Curr.)	-4.68	-3.66	-3.15	0.46	4.66	-1.88
Calculated EPS (Unit Curr.)	-4.68	-3.66	-3.15	0.46	4.66	-1.88
Calculated EPS (Adj) (Unit Curr.)	-4.68	-3.66	-3.15	0.46	4.66	-1.88
Calculated EPS (Ann.) (Unit Curr.)	-18.74	-14.63	-12.60	1.85	18.64	-7.51
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-18.74	-14.63	-12.60	1.85	18.64	-7.51
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.74	3.74	3.74	3.74	3.74	3.74
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-85.71	-18.43	-45.71	13.32	43.55	-5.63
PBDTM(%)	-97.74	-23.10	-54.29	12.54	41.50	-11.27
PATM(%)	-131.58	-33.66	-84.29	2.66	32.52	-32.86

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.45	4.45	4.45	4.45	4.45	4.45
Reserves Total	1.40	1.51	1.37	0.61	0.18	0.11
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	5.85	5.96	5.82	5.06	4.63	4.56
Secured Loans	4.00	3.81	4.27	3.77	3.94	0.00
Unsecured Loans	1.37	1.37	1.62	1.49	1.58	1.96
Total Debt	5.37	5.18	5.89	5.26	5.52	1.96
Total Liabilities	11.22	11.14	11.71	10.32	10.15	6.52
APPLICATION OF FUNDS :
Gross Block	18.38	17.45	15.92	9.64	7.04	6.96
Less : Accumulated Depreciation	8.88	7.00	5.07	0.00	2.12	1.09
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	9.50	10.45	10.85	9.64	4.92	5.87
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	3.33	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.20	0.20	0.20	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	4.31	2.85	3.95	2.72	3.97	3.22
Sundry Debtors	0.62	0.68	1.65	3.30	1.15	1.97
Cash and Bank	0.41	1.05	2.55	1.77	1.57	0.96
Loans and Advances	2.19	1.98	2.19	1.65	2.35	2.97
Total Current Assets	7.53	6.56	10.34	9.44	9.03	9.12
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	5.28	5.72	9.96	9.94	9.24	9.86
Provisions	0.97	0.93	0.84	0.73	0.31	0.25
Total Current Liabilities	6.24	6.65	10.79	10.68	9.55	10.11
Net Current Assets	1.28	-0.09	-0.45	-1.23	-0.51	-0.99
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.08	0.02
Deferred Tax Liability	0.14	0.18	0.23	0.07	0.00	0.00
Net Deferred Tax	-0.14	-0.18	-0.23	-0.07	0.08	0.02
Total Assets	10.64	10.17	10.36	8.54	8.02	4.89
Contingent Liabilities	1.00	1.00	1.00	1.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.05	2.75	1.97	1.57	0.96
Net Cash from Operating Activities	0.33	0.75	3.53	2.82	0.92
Net Cash Used In Investing Activities	-0.94	-1.53	-3.15	-2.40	-3.41
Net Cash Used In Financing Activities	-0.04	-0.91	0.40	-0.23	3.10
Net Inc./Dec In Cash And Cash Equivalents	-0.65	-1.69	0.78	0.20	0.61
Cash And Cash Equivalents At End Of The Year	0.41	1.05	2.75	1.77	1.57

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

30.83%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

69.17%

**Promoter pledged shareholding 30.83%

About Parmax Pharma Ltd

Parmax Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 11.39 crores. It has reported a sales of Rs. 1.33 crores and a net profit of Rs. -1.75 crores for the quarter ended December 2018. The company management includes , Umang Alkesh Gosalia,Ami R Shah,Yash Vora,Nikhil S. Uchat (Parmax Pharma Ltd) among others.

Chairman

Registered office

Plot No 20 Survey No 52,Tal Kotda Sangani Hadamtala,Rajkot,Gujarat,360311

FAX :

Background

Incorporation Year1994

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0